Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-10-04

Clinical Trial Update: Outpatient Ultrafiltration Therapy in Heart Failure Patients Trial [NA]

View source ↗

Summary

The outpatient ultrafiltration therapy trial for heart failure patients (NCT00319384) sponsored by Hennepin Healthcare Research Institute has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hennepin Healthcare Research Institute | Conditions: Congestive Heart Failure | NA | Status: WITHDRAWN